Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases

BACKGROUND: Median survival of non-small cell lung cancer (NSCLC) patients with brain metastases is poor. We examined concurrent erlotinib and whole brain radiotherapy (WBRT) followed by maintenance erlotinib in patients with untreated brain metastases, given the potential radiosensitizing propertie...

Full description

Saved in:
Bibliographic Details
Main Authors: Lee, Siow Ming, Lewanski, Conrad R., Counsell, Nicholas, Ottensmeier, Christian, Bates, Andrew, Patel, Nirali, Wadsworth, Christina, Ngai, Yenting, Hackshaw, Allan, Faivre-Finn, Corinne
Format: Artigo
Language:Inglês
Published: Oxford University Press 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4112798/
https://ncbi.nlm.nih.gov/pubmed/25031274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/dju151
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items